Trade AbbVie ^ABBV

AbbVie (ABBV) Receives FDA Approval for Groundbreaking BPDCN Treatment

Abbvie Gets FDA Approval for Blood Cancer Treatment | Morningstar

AbbVie (ABBV) Receives FDA Approval for Decnupaz in Rare Cancer Treatment

Ironwood Pharmaceuticals (IRWD) Gains FDA Approval for Linzess in Young Patients

AbbVie Inc. $ABBV Shares Bought by King Luther Capital Management Corp - Zolmax

Piper Sandler Raises Price Target on AbbVie (ABBV) Amid Strong IBD Pipeline Progress

Final Trades: AbbVie, Deckers and Goldman Sachs

34,517 Shares in AbbVie Inc. $ABBV Purchased by Seaview Investment Managers LLC - Zolmax

Fisher Asset Management LLC Buys 352,487 Shares of AbbVie Inc. $ABBV

MSH Capital Advisors LLC Boosts Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Holdings Raised by Fisher Asset Management LLC

Harbour Investments Inc. Purchases 146,611 Shares of AbbVie Inc. $ABBV - Stock Observer

Is EMA Backing For MAVIRET And Boey Reshaping The Investment Case For AbbVie (ABBV)?

MSH Capital Advisors LLC Increases Holdings in AbbVie Inc. $ABBV - Daily Political

Seaview Investment Managers LLC Acquires Shares of 34,517 AbbVie Inc. $ABBV - Daily Political

5 Best Retirement Stocks to Buy Now

Best Pharmaceutical Stocks To Keep An Eye On - May 25th - Stock Observer

Wealthquest Corp Makes New Investment in AbbVie Inc. $ABBV

Two Paths to Growth: Johnson & Johnson vs AbbVie - AOL

AbbVie Inc. $ABBV Shares Purchased by Legal & General Group Plc

AbbVie Inc. $ABBV Shares Sold by Simplify Asset Management Inc.

Churchill Financial Advisors LLC Purchases Shares of 20,429 AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Holdings Raised by Genus Capital Management Inc.

Legal & General Group Plc Raises Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

Wealthquest Corp Purchases New Position in AbbVie Inc. $ABBV - Daily Political

Choate Investment Advisors Sells 6,525 Shares of AbbVie Inc. $ABBV - Stock Observer

Prospera Financial Services Inc Sells 3,489 Shares of AbbVie Inc. $ABBV - Zolmax

Jefferies Financial Group Inc. Acquires 3,784 Shares of AbbVie Inc. $ABBV - Zolmax

First National Trust Co Reduces Stake in AbbVie Inc. $ABBV

Pathfinder Wealth Consulting Inc. Makes New Investment in AbbVie Inc. $ABBV - Stock Observer

Prospera Financial Services Inc Sells 3,489 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie's EMA Wins For Boey And MAVIRET Expand European Growth Story

Best Pharmaceutical Stocks To Keep An Eye On - May 23rd - Stock Observer

AbbVie (ABBV): 10 Best Low Risk Stocks to Buy in 2026

GPS Wealth Strategies Group LLC Trims Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by GPS Wealth Strategies Group LLC

Guinness Asset Management LTD Sells 37,113 Shares of AbbVie Inc. $ABBV - Stock Observer

Mizuho Markets Americas LLC Boosts Holdings in AbbVie Inc. $ABBV - Daily Political

Associated Banc Corp Cuts Stake in AbbVie Inc. $ABBV - Stock Observer

The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech

Final Trades: AbbVie, Millrose Properties, ADM, GE Vernova, Estee Lauder

Merck (MRK) and AbbVie (ABBV) Gain EU Panel Endorsements for New Treatments

AbbVie (ABBV) Receives Positive EMA Opinion for Maviret Approval

AbbVie Gets Positive Opinion From European Regulators on Hepatitis C Treatment | Morningstar

Rathbones Group PLC Lowers Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by Axxcess Wealth Management LLC

Twenty-three abstracts will highlight the versatility and st

AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline

Allergan Aesthetics Receives Positive CHMP Opinion for Boey®

AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next?

Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress | Morningstar

Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals

AbbVie Inc. (ABBV) Positioned for Long-Term Gains with IBD Pipeline Strength

AbbVie Inc. $ABBV Shares Acquired by Mach 1 Financial Group LLC - Stock Observer

AbbVie Inc. $ABBV Shares Acquired by ABN Amro Investment Solutions - Stock Observer

Assessing AbbVie (ABBV) Valuation After Recent Share Price Movement And Rich Earnings Multiple

Treat-to-target in Behçet syndrome

Hippocratic AI Expands Life Sciences Leadership Team as Pharma and Medtech Demand for Voice AI Agents Accelerates | Morningstar

Three Dividend-Paying Healthcare Giants: Pfizer (PFE), AbbVie (ABBV), and Medtronic (MDT) Compared for 2026

PNC Financial Services Group Inc. Sells 152,493 Shares of AbbVie Inc. $ABBV - Stock Observer

Cullen Frost Bankers Inc. Sells 16,653 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Harvest Portfolios Group Inc.

Is AbbVie (ABBV) Now Attractive After Mixed Returns And Conflicting Valuation Signals?

Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

AbbVie (NYSE:ABBV) Stock Price Up 2.1% - Time to Buy? - Stock Observer

BimzelxВ® Shows Superiority Over SkyriziВ® in Psoriatic Arthritis

AbbVie (ABBV) Price Target Lowered to $235 at Evercore ISI

Pharmaceutical Stocks To Follow Now - May 19th - Daily Political

ProShare Advisors LLC Sells 156,611 Shares of AbbVie Inc. $ABBV

2 Reasons to Like ABBV and 1 to Stay Skeptical

Csenge Advisory Group Purchases 12,983 Shares of AbbVie Inc. $ABBV

Gabelli Funds LLC Sells 19,750 Shares of AbbVie Inc. $ABBV

AMF Tjanstepension AB Lowers Stake in AbbVie Inc. $ABBV

Resona Asset Management Co. Ltd. Sells 24,330 Shares of AbbVie Inc. $ABBV - Stock Observer

Profund Advisors LLC Buys 7,561 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Shares Sold by Gabelli Funds LLC - Stock Observer

ProShare Advisors LLC Decreases Holdings in AbbVie Inc. $ABBV - Daily Political

Gambit Capital Management LLC Takes Position in AbbVie Inc. $ABBV - Daily Political

A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism

US pharma co denied patent on hepatitis C combo therapy

AbbVie loses patent plea for Hep C drug

AbbVie's trade secret suit against a Chinese rival gets green light

Mission Wealth Management LP Lowers Holdings in AbbVie Inc. $ABBV

60,762 Shares in AbbVie Inc. $ABBV Acquired by North Dakota State Investment Board - Stock Observer

AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC - Daily Political